Alaunos Therapeutics, Inc. Preferred Stock Dividends and Other Adjustments
Alaunos Therapeutics, Inc. (TCRT) reported Preferred Stock Dividends and Other Adjustments of $36.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2026-08-14
- Alaunos Therapeutics, Inc. preferred stock dividends and other adjustments for the quarter ending 2026-06-30 was $36.00K, a 176.92% increase year-over-year.
- Alaunos Therapeutics, Inc. preferred stock dividends and other adjustments for the quarter ending 2026-03-31 was $149.00K.
- Alaunos Therapeutics, Inc. preferred stock dividends and other adjustments for the quarter ending 2025-12-31 was $44.00K.
- Alaunos Therapeutics, Inc. preferred stock dividends and other adjustments for the quarter ending 2025-09-30 was $42.00K.
- Alaunos Therapeutics, Inc. preferred stock dividends and other adjustments for fiscal 2025 was $106.00K.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $36.00K 10-Q · filed 2026-08-14 | $71.00K 10-Q · filed 2026-08-14 | $229.00K derived: sum of 3 quarters · filed 2026-08-14 | $271.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $149.00K 10-Q · filed 2026-05-15 | $193.00K derived: sum of 2 quarters · filed 2026-05-15 | $235.00K derived: sum of 3 quarters · filed 2026-05-15 | $248.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $86.00K derived: sum of 2 quarters · filed 2026-03-31 | $99.00K derived: sum of 3 quarters · filed 2026-08-14 | $106.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $42.00K 10-Q · filed 2025-11-14 | $55.00K derived: sum of 2 quarters · filed 2026-08-14 | $62.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $13.00K 10-Q · filed 2026-08-14 | $13.00K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |